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A B S T R A C T
Ethylenediaminetetraacetic acid, ethylenediamine-N,N0-disuccinic acid and ethylene glycol-bis(2-
aminoethylether)-N,N,N0,N0-tetraacetic acid are polyaminocarboxylic acids that are able to sequester
metal ions. Calcium is implicated in maintenance of intercellular matrix, zonula occludens (tight
junctions) and zonula adherens of epithelium and endothelium cells. Corneal epithelium is impervious to
many aqueous formulations due to it being lipophilic, whereby transcellular drug transit is resisted,
whilst tight junctions restrict access via the paracellular route. Research has shown that integrity of tight
junctions breaks down through loss of Ca2+ for endothelial and epithelial cells. This study investigates
different Ca2+ sequestering compounds and their effect on corneal permeability of riboﬂavin at
physiological pH. Riboﬂavin is a topically administered ocular drug applied during UV-induced corneal
cross-linking for the treatment of keratoconus.
ã 2014 The Authors. Published by Elsevier B.V. All rights reserved.
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Administering drugs to treat ocular conditions is confronted
with many challenges despite easy access to the eye. Drug delivery
is hampered by blink action, washout by tears, mechanisms of
nasolacrimal drainage and poor permeability of the cornea
(Gilhotra et al., 2011; Kumaran et al., 2010). Once the dosage
form is applied there is only a short time where the medication is in
contact with the eye, during this time drugs intended for
intraocular tissue have to penetrate the cornea (Washington
et al., 2001). A small proportion of topically applied drugs are
absorbed into the cornea, up to 5% but often much less (Jarvinen
and Jarvinen, 1996). Most of the instilled dose is systemically
absorbed by the nasolacrimal duct and conjunctiva (Wilson et al.,
2001). The cornea is a multilayered structure consisting of ﬁve
layers: epithelium, Bowman’s membrane, stroma, Descemet’s* Corresponding author. Tel.: +44 1183786119.
E-mail address: v.khutoryanskiy@reading.ac.uk (V.V. Khutoryanskiy).
http://dx.doi.org/10.1016/j.ijpharm.2014.06.007
0378-5173/ã 2014 The Authors. Published by Elsevier B.V. All rights reserved.membrane and endothelium. The epithelium is a lipophilic layer of
around 10% of the total corneal thickness, offering a barrier of
around 90% to hydrophilic drugs and 10% to hydrophobic drugs
(Washington et al., 2001; Wilson et al., 2001). The Bowman’s
membrane forms a thin transitional layer towards the stroma,
which is the main section at 90% of the total corneal thickness
with hydrophilic gel properties comprised of collagen ﬁbrils, other
proteins and mucopolysaccharides. There exists an aqueous
environment between collagen ﬁbres, and this contributes to
the barrier function that the stroma offers against lipophilic drugs.
The next layer is the Descemet’s membrane, a tough but thin,
homogenous layer deposited by the endothelium, a single layer of
cells important in maintaining optimal corneal hydration (Wash-
ington et al., 2001; Wilson et al., 2001). Animal eyes are often used
as models when researching ocular drug delivery because they
share many of the features present in human eyes. Bovine eyes
prove to be recognized models, and these were employed in this
investigation (Chandran et al., 2008; Loch et al., 2012).
Corneal epithelium itself has further layering consisting of a
basal layer of newly formed columnar cells; these are pushed
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stage they are polyhedral shaped. Finally there is the superﬁcial
layer of polygonal shaped squamous cells, these cells have
microvilli to aid mucus adhesion, which further aids adherence
of the tear ﬁlm. Superﬁcial epithelial cells are surrounded by Ca2+
dependent cell binding sites, zonula occludens, otherwise known
as tight junctions, immediately below these are zonula adherens,
and towards the base of the cells there are spot like contact zones
known as desmosomes. The combination of these cell membrane
adherent regions and the lipophilicity of epithelia provide a very
effective barrier function that protects the eye from ingress of alien
material (Jain-Vakkalagadda et al., 2004; Kaur and Batra, 2007).
The effectiveness of the epithelium barrier is dependent on an
undetermined concentration of Ca2+ ions being available to the
plasma membrane. Calcium sequestering compounds are effective
at disrupting corneal epithelia by extracting Ca2+ ions (Kaur and
Smitha, 2002).
Polyaminocarboxylic acids are a class of synthetic compounds
with metal ion sequestering properties. Ethylenediaminetetra-
acetic acid (EDTA) is an effective calcium chelator which is
included in many ocular drug formulations as a preservative and
stabiliser (Freeman and Kahook, 2009; Grass et al., 1985); however
there are concerns regarding its accumulative toxicity towards
intraocular structures when used in the longer term. The present
study investigates the use of EDTA together with two analogues,
ethylenediamine-N,N0-disuccinic acid (EDDS) and ethylene glycol-
bis(2-aminoethylether)-N,N,N0,N0-tetraacetic acid (EGTA) for their
effectiveness as penetration enhancers in delivery of riboﬂavin for
the treatment of keratoconus and other corneal disorders (Fang-
Sheng et al., 1992; Grass et al., 1985; Meers et al., 2005; Oviedo and
Rodriguez, 2003). Around 1 in 2000 of the general population is
afﬂicted with keratoconus, a debilitating ocular condition whereby
the cornea degenerates, and the patient’s vision becomes seriously
compromised. The condition can develop to the stage where
penetrating keratoplasty (corneal transplant) becomes necessary
(Tuft et al., 1994). Wollensak et al. (2003) published their work on
development of a novel procedure for treating keratoconus by
ultraviolet A induced riboﬂavin–collagen cross-linking. This
procedure has now become a common practice for this and other
corneal degenerative conditions. However, the procedure relies on
physical abrasion of the epithelium under anaesthesia to allow
corneal permeation of riboﬂavin solution into the stroma.
Rupenthal et al. (2011) report on what they term ‘the corneal
wound healing cascade’ initiated when corneal epithelia sustain
injury, cytokines are released leading to keratocyte apoptosis
followed by several more events before eventual return to
normality. Development of a means to deliver this drug without
resorting to epithelial debridement would be a major improve-
ment on the procedure.
The present study investigates the effects of EDTA, EGTA and
EDDS calcium sequestering compounds on corneal permeability of
riboﬂavin after ﬁrst determining their Ca2+ binding ability using
isothermal titration calorimetry (ITC). We also explored corneal
integrity after exposure to these solutions. Analysis of these
solutions before and after corneal exposure was carried out using
atomic absorption spectrometry (AAS), and it was established that
they are able to extract calcium ions from corneal epithelial
membranes. Corneal barrier function was evaluated using trans-
epithelial electrical resistance analysis (TEER) to determine
changes in electrical resistance of the cornea after exposure to
Ca2+ chelating solutions. A reduction in electrical resistance
correlates to increased permeability, supporting the hypothesis
that tight junctions are dependent on Ca2+ availability (Kikuchi
et al., 2005). Permeability studies using Franz diffusion cells (FDC)
conﬁrmed that polyaminocarboxylic acids enhance corneal
permeability of riboﬂavin compared to the drug dissolved inPBS. Examination using microscopy has shown that the histology
of the epithelial barrier was altered when they were exposed to
these compounds.
2. Materials and methods
2.1. Materials
Ethylenediaminetetraacetic acid (EDTA), ethylenediamine-N,
N0-disuccinic acid (EDDS), ethylene glycol-bis(2-aminoethylether)-
N,N,N0,N0-tetraacetic acid (EGTA), 2-(N-morpholino) ethanesul-
fonic acid (MES), riboﬂavin, sodium hexane-1-sulfonate
monohydrate and glacial acetic acid were purchased from
Sigma–Aldrich (Gillingham, UK). 1000 ppm calcium calibration
standard in nitric acid, 10% w/v lanthanum chloride, calcium
chloride, sodium chloride, potassium chloride, sodium phosphate,
potassium dihydrogen phosphate, sodium hydroxide, hydrochloric
acid, optimal cutting temperature compound (OCT) and HPLC
grade ethanol were obtained from Fischer Scientiﬁc (Hemel
Hempstead, UK). Vectashield mounting medium with 40,6-
diamidino-2-phenylindole (DAPI) were obtained from Vector
Laboratories Ltd. (Peterborough, UK). MilliQ ultrapure water
(18 mV cm1) was used for all aqueous solutions. All materials
were used as supplied without modiﬁcation.
2.2. Preparation of buffer solutions
Isotonic PBS was prepared in-house and was adjusted to pH
7.4  0.2 using 0.1 M NaOH solution (Roskams and Rodgers, 2002).
Ion-pair buffer for HPLC analysis was prepared using sodium
hexane-1-sulfonate monohydrate (0.1 M) adjusted to pH 3.0  0.2
using glacial acetic acid (Anyakora et al., 2008). For isothermal
titration calorimetry, MES (10 mM) buffer was prepared and
adjusted to pH 7.4  0.2 using 1 M NaOH solution.
2.3. Isothermal titration calorimetry
ITC analysis was used to determine the Ca2+ binding properties
of EDTA, EGTA and EDDS using Microcal model ITC200 calorimeter
(cell volume = 200 mL), with ITC200 software version 1.24.2
(MicroCal Inc., USA). Data acquisition and graphical analysis was
achieved using Origin 7 SR4, v7.0552 software (OriginLab
Corporation, USA). Water was placed in the reference cell and
10 mCal s1 selected for reference power. 0.4 mM solutions of
EDTA, EGTA and EDDS in 10 mM MES buffer (pH 7.4  0.2) were
titrated by CaCl2 in 10 mM MES buffer (pH 7.4  0.2). Calcium
chloride titrant at 6 mM was used for EDTA and EGTA, a higher
concentration at 25 mM was used for EDDS in order to reach
saturation. A method with an initial injection of 0.4 mL followed by
15 injections of 2 mL with spacing of 150 s; analysis was carried out
at 25 C.
2.4. Atomic absorption spectroscopy (AAS)
Calcium ion analysis was conducted using a novAA 350 system
with WinAAS software, version 4.5.0 (Analytik JENA, Germany).
Following the method for calcium analysis published in ‘Atomic
Absorption Data Book’, brieﬂy, 50 mm stoichiometric air/acetylene
ﬂame, 422.7 nm wavelength, ultrapure water (18 mV cm1) as the
carrier (Whiteside and Milner, 1983). Quantitation achieved by
reference to a calibration curve produced from Ca2+ standards in
ultrapure water incorporating 5% w/v lanthanum chloride as a
releasing agent. Standards were prepared at Ca2+ concentrations
ranging from 0.1 to 10.0 ppm (r2 = 0.9921). Samples are diluted for
analysis by a factor of 100, therefore a lower concentration of
aqueous LaCl3 at 0.25% w/v is used for their preparation.
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Adapted low volume (5 mL each side) Ussing chambers were
used with an EVOM2 Epithelial Voltohmmeter and STX2 electrode
modiﬁed by increasing the spacing between electrodes to ﬁt
the experiment cells (World Precision Instruments, Inc., USA). The
Voltohmmeter was charged overnight prior to experiment and
calibrated with the supplied 1000 V resister after 1 h equilibration.
All solutions were degassed by sonication for 20 min, and
experiments were carried out at 34 1 C to mimic the physiologi-
cal temperature at the corneal surface (Fujishama et al., 1996; Liu
et al., 2011). Determination of baseline electrical resistance of the
PBS solution in the experiment cell was measured without a
membrane in place preceding measurement of corneal resistance.
An initial measurement was taken at <5 min (t0) then at 30 min
intervals for 2 h. PBS solution (pH 7.4) was used in the receiving
chamber, and solutions of 1 mg mL1 EDTA, EGTA or EDDS in PBS
were added to the donor chamber. TEER values were calculated
using the following equation:
TEER ¼ Resistance; kV  membranearea; cm2 (1)
2.6. HPLC analysis
Analysis was conducted using a PerkinElmer series 200 HPLC
system comprising of 785 A UV–vis detector, series 200 quaternary
pump and series 200 autosampler (PerkinElmer Inc., UK),
Hamilton PRP-1 reversed phase column, 150 mm  4.1 mm,
10 mm (part number: 79425) and data acquisition software
(Peaksimple, version 4.09, SRI Inc., USA). Analysis of riboﬂavin
was achieved with a run time of 5 min using the method developed
by us. Isocratic conditions were used at 25 C with the mobile
phase comprising of 20% ethanol and 80% ion-pair buffer, ﬂow rate
0.8 mL min1, 10 mL injection volume, UV detector at 267 nm
corresponding to riboﬂavin absorption lmax, a retention time of
3.05 min. Quantitation was achieved by reference to a calibration
curve produced from riboﬂavin standards in PBS, pH 7.4  0.2 at
concentrations ranging from 0.01 to 25 mg mL1 (r2 = 0.9996).
2.7. Preparation of animal tissues
For Franz diffusion cell experiments, bovine corneas were
dissected within 4 h of slaughter using a sharp blade, the cornea
with 2–3 mm of sclera was carefully excised, rinsed with PBS,
wrapped in cling ﬁlm to prevent dehydration and stored for up to
four days at 4 C. For whole eye experiments, the eyes were stored
for up to two days at 4 C. Each experiment was carried out in
triplicate using a different eye or cornea for each repeat.
2.8. Whole eye experiments
Using an experimental procedure previously developed and
reported by us (Morrison et al., 2013), brieﬂy, fresh whole bovine
eyes were placed in 150 mL beakers, cornea facing uppermost. A
Franz diffusion cell donor chamber was placed on the cornea as a
means to contain the dose; the setup was wrapped in cling-ﬁlm
ensuring a good seal between the donor chamber and the cornea;
these were placed in a water bath at 34 1 C. Individual eyes were
exposed to PBS or solutions of EDTA, EGTA or EDDS at 1 mg mL1 in
PBS, all at pH 7.4  0.2 by placing 1 mL solution onto the cornea.
After 3 h, the solutions were recovered and placed in micro-
centrifuge tubes, centrifuged at 10,000 rpm for 10 min. Samples of
solutions before corneal exposure and each supernatant from
cornea exposed solutions were diluted by 100 in 0.25% w/v LaCl3
aqueous solution for analysis using established methods for atomic
absorption spectrometry.2.9. Corneal integrity
From the above experiment, corneas were dissected after
exposure, and sections were prepared for microscopy by setting
cornea segments in OCT, quick freezing on dry ice and subsequent
sectioning. Specimens of 7 mm thickness were prepared using a
microtome (Bright, model 5040, UK) and cryostat (Bright, model
OTF, UK) placed in groups of four to six on 75 mm  25 mm glass
slides, dried in a warm air stream for 10 min. Specimens were
stained using Vectashield with DAPI mounting medium, and a glass
coverslip applied. All cornea sections were examined within seven
days of preparation using an AXIOCAM MRm 1.3 MP digital camera
attached to a Zeiss AXIO Imager A1 ﬂuorescent microscope, using
AXIO Vs 40 V.4.8.2.0 software (Zeiss, Oberkochen, Germany). A 10
magniﬁcation eyepiece together with a 5 magniﬁcation objective
lens was employed, and DAPI ﬂuorescence ﬁlter was selected.
2.10. Effect of calcium sequestering compounds on riboﬂavin
permeability
Corneal permeability of riboﬂavin was studied in vitro using
Franz diffusion cells. Solutions of EDTA, EDDS and EGTA at
concentration of 1 mg mL1 in PBS, pH 7.4  0.2 were prepared;
riboﬂavin was added at 0.1 mg mL1. A solution of riboﬂavin in PBS,
pH 7.4  0.2 was also prepared as a control. Bovine corneas were
mounted in Franz diffusion cells (FDC), epithelium side facing the
donor compartment. The receiver compartment was ﬁlled with
pre-warmed and degassed PBS (16.5 mL). Prepared FDCs were
placed in a water bath, stirred at 34 1 C. 1 mL of the prepared
solutions were added to the donor compartment and sealed with
ﬁlm to prevent evaporation. Riboﬂavin is known to be photode-
gradable (Terekhova et al., 2011), therefore the whole experiment
was shielded with aluminium foil. Sink conditions were employed
with 0.4 mL aliquots taken every 60 min for 240 min. HPLC analysis
was carried out immediately after all samples had been collected to
avoid drug degradation. Apparent permeability and steady-state
ﬂux were calculated using the following equation:
Papp ¼ DQ
Dt60AC0
(2)
where Papp is the apparent permeability of riboﬂavin through
bovine cornea, Q is total drug permeated at time t, DQ/Dt is the
steady-state ﬂux into the receiving solution (mmol min1) which
equates to the gradient of the linear portion of the graph, 60 is
minutes to seconds conversion factor, A is the area of exposed
cornea (1.54 cm2) and C0 is the initial amount of drug added to the
donor chamber (Jarho et al., 1996).
2.11. Cornea extracts
Corneas from the riboﬂavin permeability experiment were
trimmed of sclera, gently blotted with tissue paper, weighed and
placed in glass vials to which 5 mL absolute ethanol was added to
extract absorbed riboﬂavin. Differences in its accumulation within
the corneas between different solutions were compared. The vials
were stored at room temperature shielded from light for three
days. From these vials, 1 mL of extract solvent was centrifuged at
10,000 rpm for 10 min, and the supernatant transferred to
autosample vials for HPLC analysis.
3. Results and discussion
3.1. Ca2+ sequestering properties of EDTA, EGTA and EDDS
EDTA is already known for its Ca2+ sequestering properties and
has applications in many industries including cosmetics, food
Fig. 1. Isotherms for Ca2+ titration of 0.4 mM EDTA, EGTA and EDDS, concentration of Ca2+ was 6 mM for EDTA and EGTA, and 25 mM for EDDS.
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EDDS and EGTA are analogues, and these were investigated as
possible alternatives to potentially enhance the permeability of
riboﬂavin into the cornea. Ca2+ plays an important role in the barrier
function of corneal epithelium, and it was hypothesised that
extracting these ions from the corneal membrane could enhance
drug permeation. Ca2+ binding efﬁciency was investigated using
isothermal titration calorimetry. Atomic absorption spectrometry
was used to study Ca2+ extraction from the cornea, and corneal
integrity was determined by examination using ﬂuorescence
microscopy. In vitro studies compared riboﬂavin permeability
enhancement through the cornea, and solvent extraction was used
to determine the levels of riboﬂavin taken up by the cornea. TEER
analysis measured changes in electrical resistance of the cornea,
and this correlates with changes in riboﬂavin permeability.
3.2. Isothermal titration calorimetry
ITC was used to determine Ca2+ binding efﬁciency of EDTA, EGTA
and EDDS solutions at physiological pH 7.4. Fig. 1 shows individual
raw data and corresponding isotherms of the respective compounds
titrated with CaCl2. Traces for EDTA and EGTA show an exothermic
trend, which agrees with the literature (Griko, 1999; Keowmanee-
chai and McClements, 2002; Henzl et al., 2003), whilst the
interaction of EDDS with Ca2+ is endothermic under the experimen-
tal conditions. Measured values of enthalpy (DH), stoichimetry (N),
binding afﬁnity (Kb) and entropy (DS) from this analysis are shown
in Table 1. EDTA and EGTA have strong binding afﬁnity (Kb) of
(1.20  0.17)  106M1 and (1.41 0.26)  105M1, respectively,
whereas EDDS has a much lower Kb of (3.06  0.24)  103M1.
Complexation mechanisms of metal ion – chelator binding are
not fully understood; however, we found that all 3 compounds
investigated in this study have afﬁnity for Ca2+ sequestration.Table 1
ITC analysis at pH 7.4  0.2 of EDTA, EGTA and EDTA titrated with CaCl2.
Chelator in 10 mM MES CaCl2 in 10 mM MES Stoichiometry, N 
EDTA (0.4 mM) 6 mM 1.12  0.06 
EGTA (0.4 mM) 6 mM 1.34  0.29 
EDDS (0.4 mM) 25 mM 1.55  0.04 Polyaminocarboxylic acids have pH dependent zwitterionic
structures, i.e. they are molecules carrying multiple positive and
negative charges. Metal ion afﬁnity is more favourable under
mildly acidic conditions for EDTA and possibly EGTA, whilst
slightly alkaline conditions are required by EDDS (Yip et al., 2010).
Hydrogen bonding and proton transfer play an important role in
chemical complexation (Chandra et al., 2000; Ho et al., 2003). Fig. 2
shows the chemical structures of these 3 compounds and an
example of metal ion complex (Zeng et al., 2014). They have
different numbers of H-bond donor/acceptor sites: EDTA has 4
donor and 10 acceptor sites, EGTA has 4 donors and 12 acceptors,
and EDDS has 6 donors and 10 acceptors. Secondly, the carboxylic
acid structures of EDTA and EGTA are similar in that these groups
are ‘open’ in comparison with the corresponding groups of EDDS
where they form ring-like entities; in this case, there is more
likelihood that the OH groups may form intramolecular H-bonds
rather than interacting with Ca2+. The carbon chain link between
the carboxylic acid groups at each side of the molecule is shorter
for EDTA than for EGTA, therefore the distance for bonding
between Ca2+ and carboxylic acid groups is less; this could be the
reason for the order of magnitude difference in binding afﬁnity
between EDTA and EGTA. Considering these variations could
explain the observed differences in Ca2+ sequestering performance
between these compounds.
3.3. Whole eye experiments
Experiments were conducted to determine Ca2+ extraction from
the cornea using Ca2+ chelators. An area of cornea (1.54  0.22 cm2)
was exposed to calcium sequestering solutions at a concentration of
1 mg mL1 in isotonic PBS at pH 7.4  0.2, another set of eyes were
exposed to PBS under the same conditions. After 3 h, the solutions
were recovered,centrifugedat10,000 rpm for 10 min and asample ofBinding afﬁnity, Kb (M1) DH (kJ mol1) DS (kJ mol1 deg1)
(1.20  0.17)  106 11.55  0.25 77.70  1.88
(1.41  0.26)  105 13.10  0.42 54.68  2.80
(3.06  0.24)  103 4.03  0.38 80.21  0.63
Fig. 2. Chemical structures of EGTA, EDTA and EDDS and an example of EDTA/metal ion complex.
Fig. 3. Calcium concentration in solutions containing PBS and Ca2+ sequestering
compounds (1 mg mL1) before and after 3 h exposure to bovine cornea. *P < 0.05,
**P < 0.01, ***P < 0.001, one-way ANOVA, n = 3.
60 P.W.J. Morrison, V.V. Khutoryanskiy / International Journal of Pharmaceutics 472 (2014) 56–64supernatant diluted with 0.25% w/v LaCl3 in ultrapure water
(18 mV cm1) for AAS analysis. Ca2+ is a persistent species within
our environment, in water, on glassware and as an impurity in many
reagent grade chemicals, therefore ultrapure water (18 mV cm1)
wasusedtorinsetheglasswareandtomakeuptheaqueoussolutions
for these experiments. There still remains an element of Ca2+
contamination from impurities in reagents and our working
environment, therefore calcium was measured in solutions before
and after theywere exposed to corneas.This investigationhas shown
that calcium sequestering compounds capture Ca2+ from the cornea
above this ‘background’ level. Fig. 3 shows differences in calcium
content of solutions before corneal contact compared to the same
solutions after exposure. All formulations show a net increase in Ca2+
concentration at the end of this experiment, and the rank order of
calcium sequestering performance from bovine cornea compared to
PBS solution is PBS (54.67  7.04 ppm) < EDDS**(87.60  3.30 ppm)
< EDTA**(98.97  9.86 ppm) < EGTA*(119.57  27.28 ppm); howev-
er, when applying statistical analysis for performance between
EDTA, EGTA and EDDS there are no signiﬁcant differences. *P < 0.05,
**P < 0.01, ***P < 0.001, one-way ANOVA, n = 3.
3.4. TEER analysis
Transepithelial electrical resistance (TEER) measurement is a
technique useful in determining the barrier function of epithelialmembranes. These membranes are polar and selective to ion-
transport whilst they exclude macromolecules (Tang and Good-
enough, 2003; Brown and Stow, 1996). TEER values of membranes
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Fig. 4. TEER analysis for PBS, EDDS, EGTA and EDTA exposed bovine corneas. Error
bars have been omitted for clarity and are included on individual graphs in the
supplementary information.
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correspond to less permeable membranes and vice versa, therefore
having a means to measure changes in resistance is a convenientFig. 5. Micrographs showing histological changes due to exposure to calcium sequesterin
to PBS (a). (a) PBS, (b) EDDS, (c) EGTA and (d) EDTA. Scale bar = 100 mm.tool that can be used to evaluate the effect of compounds applied to
tissue.
Baseline resistance of PBS solution in the experiment cells
without a membrane was found to be 0.227  0.01 kV, and this was
deducted from the measured corneal TEER values. Measurements
for corneal resistance using PBS (control) and EDDS, EGTA and
EDTA solutions (1 mg mL1) in the donor chambers were taken.
Fig. 4 shows the differences in calculated TEER values at 30 min
intervals up to 120 min after deducting the baseline between the
control and chelator exposed corneas. The initial TEER values
recorded for bovine corneas were 2.28  0.06 kV cm2, which is in
good agreement with the literature (Kikuchi et al., 2005). Electrical
resistance reduced for corneas exposed to PBS from 2.28  0.06 to
1.93  0.04 kV cm2 over 2 h, and this is due to the corneal swelling
observed when using in vitro techniques. However, the reduction in
electrical resistance was enhanced when using chelators in PBS.
The values for these formulations were reduced to 1.62  0.04,
1.42  0.02 and 1.38  0.03 kV cm2 over the same timescale for
EDDS, EGTA and EDTA, respectively. At 120 min, TEER values were
signiﬁcantly reduced for PBS solutions containing 1 mg mL1 of
EDDS, EGTA or EDTA compared with the PBS control (one-way
ANOVA, P < 0.01, n = 4). EGTA and EDTA show a signiﬁcantly better
ability to reduce TEER values compared to EDDS (one-way ANOVA,
P < 0.01, n = 4).g formulations at a concentration of 1 mg mL1 for 3 h (b–d) compared to exposure
Fig. 6. Calcium chelator enhanced riboﬂavin permeability through bovine cornea
(chelators at 1 mg mL1 with riboﬂavin at 0.1 mg mL1). Error bars have been
omitted for clarity and have been included on individual plots in supporting
information. *P < 0.05, **P < 0.01, one-way ANOVA, n = 4.
0 
50 
100 
150 
200 
250 
PBS  EDDS ED TA EG TA 
R
ib
of
la
vi
n,
 n
g 
*
**
Fig. 7. Comparative enhancement of riboﬂavin absorption into bovine corneas
using calcium chelators (chelators at 1 mg mL1 with riboﬂavin at 0.1 mg mL1).
*P < 0.05, **P < 0.01, one-way ANOVA, n = 3.
62 P.W.J. Morrison, V.V. Khutoryanskiy / International Journal of Pharmaceutics 472 (2014) 56–643.5. Corneal integrity
Previously we have reported a new technique to study the
histological changes taking place in bovine cornea after exposing
them to cyclodextrins (Morrison et al., 2013). In the present study
we employed a similar method to investigate the effect of calcium
chelators on the cornea. The dissected corneas from the whole eye
experiment were examined using ﬂuorescence microscopy, and
there is clear evidence of histological changes between corneas
exposed PBS or Ca2+ sequestering formulations in PBS (Fig. 5). The
cornea shown in Fig. 5a was exposed to PBS, Fig. 5b EDDS, Fig. 5c
EGTA and Fig. 5d EDTA, all at pH 7.4  0.2 with calcium
sequestering formulations at 1 mg mL1 in PBS. The epithelium
shows no evidence of disruption for the corneas exposed to PBS
(Fig. 5a), whilst the solutions of PBS with calcium chelators show
disruption to the epithelium (Fig. 5b–d). EDDS and EDTA appear to
cause some swelling with voids throughout this layer; perforation
seems to penetrate the whole of the epithelium for EDTA. With
EGTA, there is evidence of intense disruption to the superﬁcial
epithelial layers and a relatively undisturbed basal layer. These
ﬁndings correlate with the above-discussed results where it was
found that PBS had only moderate ability to extract Ca2+ upon
corneal exposure, whereas the sequestering compounds were able
to extract signiﬁcantly more. EDDS extracted the least amount of
Ca2+ closely followed by EDTA, whilst EGTA sequestered the largest
amount.
3.6. Corneal permeability of riboﬂavin
This part of the investigation compared the in vitro
permeability of riboﬂavin at a concentration of 0.1 mg mL1 in
PBS (pH 7.4  0.2) to the same concentration of riboﬂavin in PBS
with EDTA, EDDS or EGTA at 1 mg mL1 (pH 7.4  0.2) through
bovine cornea using Franz diffusion cells. For all solutions, a lag-
time of 120 min was observed before any evidence of riboﬂavin
permeation was detected, after which any differences in riboﬂavin
permeability through the cornea between the various formula-
tions could be measured (Fig. 6); this is in good agreement withTable 2
Steady state ﬂux and apparent permeability of riboﬂavin in PBS with and w
Riboﬂavin solution (0.266 mM) in: Steady-sta
PBS 0.0478  
EDTA (1 mg mL1) 0.1015  
EDDS (1 mg mL1) 0.0782  
EGTA (1 mg mL1) 0.1108  our results on Ca2+ extraction, TEER analysis and corneal integrity.
The factors affecting the observed lag time are due the initial
accumulation of riboﬂavin into the stromal reservoir until there is
sufﬁcient amount to further transport out from the cornea into the
receiving solution. Once riboﬂavin starts to move through the
cornea, its concentration within the receiving solution would
initially be below the limit of quantiﬁcation which is 1 ppm,
increasing with time. At 240 min the measured concentration of
riboﬂavin in the receiving solution was 5.74  0.96 ng mL1 in PBS,
9.38  3.89 ng mL1 in EDDS, 12.18  2.76 ng mL1 in EDTA, and
13.30  1.40 ng mL1 in EGTA.
Calculating the steady state ﬂux and apparent permeability
(Papp) of riboﬂavin across bovine cornea was shown to be
enhanced using calcium sequestering formulations compared to
riboﬂavin in PBS. EGTA performed the best, closely followed by
EDTA then EDDS with Papp of 4.508  103, 4.130  103 and
3.182  103 cm s1, respectively, this compares with riboﬂavin in
PBS at 1.945 103 cm s1 (Table 2).
3.7. Cornea extracts
When treating keratoconus, the aim is to deliver riboﬂavin into
the corneal stroma where it then mediates UVA induced collagen
cross-linking, therefore for this part of the study the amount of
drug absorbed into the cornea for each different formulation was
measured. During the riboﬂavin permeability experiments above,
corneas were dosed with riboﬂavin formulations in PBS with or
without calcium sequestering compounds. At the end of the
riboﬂavin permeability experiments, the FDC’s were disassembled,
and the corneas were trimmed to exclude any scleral tissue.
Riboﬂavin was extracted using ethanol with subsequent analysis
by HPLC. Fig. 7 shows the differences in amount of riboﬂavin
absorbed by corneas using different formulations; there is a
signiﬁcant difference between experiments for riboﬂavin in PBS
and formulations which include calcium chelators. In the corneas
where riboﬂavin in PBS was applied, we see a mean amount of
50.41 2.80 ng riboﬂavin extracted, formulations including EDDS
show a slight but signiﬁcant improvement at 64.41 7.41 ng, for
EDTA and EGTA we see a marked increase to 161.48  39.34 ng and
157.75  31.00 ng, respectively.ithout calcium sequestering compounds.
te ﬂux (mmol min1) Papp (cm s1103)
0.0080 1.945  0.325
0.0230 4.130  0.935
0.0324 3.182  1.319
0.0117 4.508  0.475
Table 3
Riboﬂavin extracted from treated corneas, pg:mg.
Solution (pH 7.4  0.2) Riboﬂavin pg mg1 cornea
PBS 62.46  0.98
EDDS (1 mg mL1) 76.08  7.46**
EDTA (1 mg mL1) 180.44  38.55**
EGTA (1 mg mL1) 187.54  30.16**
** P < 0.01, one-way ANOVA, n = 3.
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picogram per milligram of cornea. Comparing these values with
those for riboﬂavin in PBS which had a value of 62.46 pg mg1,
EDDS had a slightly higher but signiﬁcant mean riboﬂavin content
of 76.08 pg mg1, EDTA had a much higher value of 180.44 pg mg1
and EGTA had the highest level at 187.54 pg mg1.
These results correlate with the ﬁndings from other experi-
ments within this investigation.
4. Conclusions
In this series of experiments we tested the hypothesis that
calcium plays an important role in the barrier function of the
cornea against riboﬂavin penetration. Ca2+ sequestration is
possible using polyaminocarboxylic acids, and these compounds
were central to this investigation. The well-known and reported
compound EDTA was compared with 2 of its analogues, EGTA
and EDDS and their performance against a PBS control was
compared from many angles. First, their ability to bind with Ca2+
was measured using isothermal titration calorimetry, and it was
found that as compared with PBS polyaminocarboxylates have
superior capacity to form complexes with calcium ions. Second,
using atomic absorption spectrometry, their ability to extract Ca2+
from the corneal epithelium was shown to be signiﬁcantly higher
than solutions without these compounds when formulations
were analysed before and after corneal exposure. Transepithelial
electrical resistance was measured for corneas exposed to these
compounds and compared to TEER values of corneas exposed to
PBS. It was demonstrated that Ca2+ chelators were effective at
reducing electrical resistance of corneal membranes, supporting
the hypothesis that Ca2+ plays an important role in maintaining
epithelial barrier function. Next, any effect on corneal integrity
was examined using microscopy, and some very distinct
histological changes became evident between the PBS control
and sequestering formulations. Crucially, the next set of experi-
ments tested any enhancement to riboﬂavin permeability
through the cornea, and it was found that all the sequestering
compounds investigated in this study brought improved drug
permeability compared with riboﬂavin in PBS. Finally the amount
of riboﬂavin absorbed by the cornea was determined in an
experiment designed to extract the drug from corneas used in
these experiments, and again it was found that formulations
incorporating polyaminocarboxylates were superior to formula-
tions without any enhancement. Across the whole series of
experiments, a pattern emerged; it was found that all Ca2+
sequestering formulations performed better than the PBS control.
In all cases, EDDS brought moderate enhancement, whilst EDTA
and EGTA brought a marked improvement in performance.
Further work could consider implications regarding epithelial
recovery after treatment using calcium chelators.
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